Loss of Ezh2 synergizes with JAK2-V617F in initiating myeloproliferative neoplasms and promoting myelofibrosis.
J Exp Med
; 213(8): 1479-96, 2016 07 25.
Article
in En
| MEDLINE
| ID: mdl-27401344
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Hematologic Neoplasms
/
Mutation, Missense
/
Tumor Suppressor Proteins
/
Janus Kinase 2
/
Enhancer of Zeste Homolog 2 Protein
/
Myeloproliferative Disorders
Limits:
Animals
Language:
En
Journal:
J Exp Med
Year:
2016
Document type:
Article
Affiliation country:
Switzerland
Country of publication:
United States